Harnessing AI & Machine Learning to Unlock New Strategies in Innate Immunotherapy for Faster, More Effective Treatments

• Applying AI-driven analysis to develop predictive models of donor performance
• Leveraging machine learning models to guide CAR-NK engineering and manufacturing decisions
• Integrating machine learning into preclinical and clinical workflows to continuously improve product efficacy

Speakers:

Nina Horowitz

Chief Executive Officer

ImmuneBridge